Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the safety and efficacy of ABT-450, ritonavir and ABT-267 (ABT-450/r/ABT-267; ABT-267 also known as ombitasvir) and ABT-333 (also known as dasabuvir) co-admini...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
AbbVie (prior sponsor, Abbott)
NCT01866930 · Chronic Hepatitis C Infection
NCT02333292 · Chronic Hepatitis C Infection
NCT02219503 · Chronic Hepatitis C Infection, Compensated Cirrhosis
NCT01704755 · Chronic Hepatitis C Infection, Compensated Cirrhosis
NCT00854087 · Chronic Hepatitis C Infection
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions